{"transactions":[{"id":804902,"issuer":{"id":642,"kind":"organization","name":"HP INC","symbol":"HPQ"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-20T21:43:41.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":12176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of HP common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person elected to defer the receipt of common stock until 04/01/2033."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On 04/16/2026, the reporting person was granted 12,176 RSUs, all of which vested on the grant date."}],"balance_after":12176,"derivative":{"underlying":"Common Stock","underlying_shares":12176},"source":{"system":"sec-edgar","filing":"0001444612-26-000002","document":"form4-04202026_090436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/47217/000144461226000002/form4-04202026_090436.xml","form_type":"4"}},{"id":1171490,"issuer":{"id":642,"kind":"organization","name":"HP INC","symbol":"HPQ"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-16T21:05:57.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":9568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of HP common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"On 04/14/2025, the reporting person was granted 9,568 RSUs, all of which vested on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On 04/14/2025, the reporting person was granted 9,568 RSUs, all of which vested on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On 04/14/2025, the reporting person was granted 9,568 RSUs, all of which vested on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person elected to defer the receipt of common stock until 04/01/2032."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On 04/14/2025, the reporting person was granted 9,568 RSUs, all of which vested on the grant date."}],"balance_after":9568,"derivative":{"underlying":"Common Stock","underlying_shares":9568},"source":{"system":"sec-edgar","filing":"0000950170-25-054843","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/47217/000095017025054843/ownership.xml","form_type":"4"}},{"id":1473060,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T20:56:31.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":24134,"derivative":{"exercise_price":1.65,"exercise_date":"2024-07-18","expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":24134},"source":{"system":"sec-edgar","filing":"0001299130-24-000151","document":"wk-form4_1718916984.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444612/000129913024000151/wk-form4_1718916984.xml","form_type":"4"}},{"id":1473059,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:56:31.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":17116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest on the one (1) year anniversary of the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":57116,"source":{"system":"sec-edgar","filing":"0001299130-24-000151","document":"wk-form4_1718916984.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444612/000129913024000151/wk-form4_1718916984.xml","form_type":"4"}},{"id":1536608,"issuer":{"id":642,"kind":"organization","name":"HP INC","symbol":"HPQ"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-24T21:01:38.000Z","date":"2024-04-22","kind":"grant","planned":false,"acquired":true,"shares":7943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 22, 2024, the reporting person was granted 7,943 restricted stock units, all of which vested on the grant date."}],"balance_after":10690,"source":{"system":"sec-edgar","filing":"0000950172-24-000228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/47217/000095017224000228/form4.xml","form_type":"4"}},{"id":1591484,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T22:36:07.000Z","date":"2024-03-06","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":4.404,"value":176160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This purchase price represents the weighted average purchase price of the shares acquired ranging from $4.38 to $4.44 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001299130-24-000076","document":"wk-form4_1709764557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444612/000129913024000076/wk-form4_1709764557.xml","form_type":"4"}},{"id":1750931,"issuer":{"id":642,"kind":"organization","name":"HP INC","symbol":"HPQ"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-03T21:17:00.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":2747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2023, the reporting person was granted 2,747 restricted stock units, all of which vested on the grant date. This grant reflects pro-rated annual equity retainer for his first partial year of service as a member of HP's Board of Directors."}],"balance_after":2747,"source":{"system":"sec-edgar","filing":"0001209191-23-054388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/47217/000120919123054388/doc4.xml","form_type":"4"}},{"id":1759816,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-16T12:15:40.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":86954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Meline was elected to the Board of Directors on October 13, 2023. One-third of the shares subject to the option will vest on the one year anniversary of Mr. Meline joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date."}],"balance_after":86954,"derivative":{"exercise_price":7.98,"exercise_date":"2024-10-13","expiration_date":"2033-10-13","underlying":"Common Stock","underlying_shares":86954},"source":{"system":"sec-edgar","filing":"0001299130-23-000124","document":"wk-form4_1697458523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444612/000129913023000124/wk-form4_1697458523.xml","form_type":"4"}},{"id":2188152,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-11T20:52:56.000Z","date":"2022-08-09","kind":"exercise","acquired":false,"shares":348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":3482,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":348},"source":{"system":"sec-edgar","filing":"0001127602-22-020829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222020829/form4.xml","form_type":"4"}},{"id":2188151,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-11T20:52:56.000Z","date":"2022-08-10","kind":"sale","acquired":false,"shares":164,"price":173.6626,"value":28480.6664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive\n  plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":2857,"source":{"system":"sec-edgar","filing":"0001127602-22-020829","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222020829/form4.xml","form_type":"4"}},{"id":2188150,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-11T20:52:56.000Z","date":"2022-08-09","kind":"exercise","acquired":true,"shares":348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 90 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on May 31, 2022."}],"balance_after":3021,"source":{"system":"sec-edgar","filing":"0001127602-22-020829","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222020829/form4.xml","form_type":"4"}},{"id":2274804,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-11T20:26:50.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":3830,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":348},"source":{"system":"sec-edgar","filing":"0001127602-22-014148","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222014148/form4.xml","form_type":"4"}},{"id":2274803,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-11T20:26:50.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":156,"price":133.7138,"value":20859.3528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive\n  plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":2583,"source":{"system":"sec-edgar","filing":"0001127602-22-014148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222014148/form4.xml","form_type":"4"}},{"id":2274802,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-11T20:26:50.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":348,"price":134.4,"value":46771.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":2739,"source":{"system":"sec-edgar","filing":"0001127602-22-014148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222014148/form4.xml","form_type":"4"}},{"id":2354541,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T21:58:29.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":6415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this restricted stock unit award will vest on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the shares subject to this restricted stock unit award will vest on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":6415,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6415},"source":{"system":"sec-edgar","filing":"0001127602-22-008037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222008037/form4.xml","form_type":"4"}},{"id":2354540,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T21:58:29.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":26020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option will vest and become exercisable on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":26020,"derivative":{"exercise_price":149.52,"exercise_date":"2023-03-01","expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":26020},"source":{"system":"sec-edgar","filing":"0001127602-22-008037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222008037/form4.xml","form_type":"4"}},{"id":2401659,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-11T21:33:40.000Z","date":"2022-02-09","kind":"exercise","acquired":false,"shares":1392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":4178,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1392},"source":{"system":"sec-edgar","filing":"0001127602-22-004566","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222004566/form4.xml","form_type":"4"}},{"id":2401658,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-11T21:33:40.000Z","date":"2022-02-10","kind":"sale","acquired":false,"shares":619,"price":158.892,"value":98354.148,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive\n  plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":2391,"source":{"system":"sec-edgar","filing":"0001127602-22-004566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222004566/form4.xml","form_type":"4"}},{"id":2401657,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-11T21:33:40.000Z","date":"2022-02-09","kind":"exercise","acquired":true,"shares":1392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 118 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on November 30, 2021."}],"balance_after":3010,"source":{"system":"sec-edgar","filing":"0001127602-22-004566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222004566/form4.xml","form_type":"4"}},{"id":2866712,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-12T00:23:25.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":5570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this restricted stock unit award will vest on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the shares subject to this restricted stock unit award will vest on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":5570,"derivative":{"exercise_price":0,"exercise_date":"2022-02-09","underlying":"Common Stock","underlying_shares":5570},"source":{"system":"sec-edgar","filing":"0001127602-21-005296","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760221005296/form4.xml","form_type":"4"}},{"id":2866711,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-12T00:23:25.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":25618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option will vest and become exercisable on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":25618,"derivative":{"exercise_price":179.52,"exercise_date":"2022-02-09","expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":25618},"source":{"system":"sec-edgar","filing":"0001127602-21-005296","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760221005296/form4.xml","form_type":"4"}},{"id":2911045,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T21:14:45.000Z","date":"2020-07-06","kind":"grant","acquired":true,"shares":271303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option will vest and become exercisable on July 6, 2021 with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":271303,"derivative":{"exercise_price":59.15,"expiration_date":"2030-07-06","underlying":"Common Stock","underlying_shares":271303},"source":{"system":"sec-edgar","filing":"0001127602-21-001413","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760221001413/form4.xml","form_type":"4"}},{"id":110189,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-11-25T23:27:17.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":8737,"price":234.36,"value":2047603.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,523 RSUs which vest in one installment on 5/3/2020; 2,885 RSUs which vest in installments of 1,421 on 5/1/2020 and 1,464 on 5/1/2021; 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022; and 4,511 which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 637 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":49378,"source":{"system":"sec-edgar","filing":"0001127602-19-033709","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219033709/form4.xml","form_type":"4"}},{"id":116887,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Nqso (Right to Buy)","published_at":"2019-05-07T23:00:22.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":39382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively."}],"balance_after":39382,"derivative":{"exercise_price":177.31,"exercise_date":"2021-05-03","expiration_date":"2029-05-03","underlying":"Common Stock","underlying_shares":39382},"source":{"system":"sec-edgar","filing":"0001127602-19-017650","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017650/form4.xml","form_type":"4"}},{"id":116886,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-05-07T23:00:22.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":4511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These Restricted Stock Units (RSUs) were granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 1,523 RSUs which vest on 5/3/2020; 2,885 RSUs which vest in installments of 1,421 on 5/1/2020 and 1,464 on 5/1/2021; 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022; and 4,511 which will vest in installments of 1,488 on 5/3/2021, 1,489 on 5/3/2022 and 1,534 on 5/3/2023.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 425 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":57903,"source":{"system":"sec-edgar","filing":"0001127602-19-017650","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017650/form4.xml","form_type":"4"}},{"id":116885,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-05-07T23:00:22.000Z","date":"2019-05-03","kind":"tax_withholding","acquired":false,"shares":795,"price":176.5,"value":140317.5,"ownership":{"direct":true},"balance_after":53392,"source":{"system":"sec-edgar","filing":"0001127602-19-017650","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017650/form4.xml","form_type":"4"}},{"id":117037,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-05-03T21:49:21.000Z","date":"2019-05-01","kind":"tax_withholding","acquired":false,"shares":746,"price":179.3232,"value":133775.1072,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which vest in installments of 1,477 on 5/3/2019 and 1,523 on 5/3/2020; 2,885 RSUs which vest in installments of 1,421 on 5/1/2020 and 1,464 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 550 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":54187,"source":{"system":"sec-edgar","filing":"0001127602-19-017343","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017343/form4.xml","form_type":"4"}},{"id":118127,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-03-25T23:36:37.000Z","date":"2019-03-22","kind":"tax_withholding","acquired":false,"shares":8040,"price":191.89,"value":1542795.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which vest in installments of 1,477 on 5/3/2019 and 1,523 on 5/3/2020; 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 631 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":54933,"source":{"system":"sec-edgar","filing":"0001127602-19-013162","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219013162/form4.xml","form_type":"4"}},{"id":118674,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-03-09T00:40:08.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":16086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which vest in installments of 1,477 on 5/3/2019 and 1,523 on 5/3/2020; 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 533 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":62746,"source":{"system":"sec-edgar","filing":"0001127602-19-010656","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219010656/form4.xml","form_type":"4"}},{"id":120689,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-02-01T23:18:07.000Z","date":"2019-01-30","kind":"tax_withholding","acquired":false,"shares":528,"price":192.11,"value":101434.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which vest in installments of 1,477 on 5/3/2019 and 1,523 on 5/3/2020; 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 533 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":46660,"source":{"system":"sec-edgar","filing":"0001127602-19-003508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219003508/form4.xml","form_type":"4"}},{"id":121269,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2019-01-15T01:44:19.000Z","date":"2018-11-28","kind":"gift","acquired":false,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported involved a gift by the reporting person of shares of the Company's common stock to a charitable donor advised fund."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 3,000 RSUs which vest in installments of 1,477 on 5/3/2019 and 1,523 on 5/3/2020; 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 674 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":47188,"source":{"system":"sec-edgar","filing":"0001127602-19-001941","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219001941/form5.xml","form_type":"5"}},{"id":126293,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2018-08-02T22:36:49.000Z","date":"2018-08-01","kind":"tax_withholding","acquired":false,"shares":7382,"price":196.55,"value":1450932.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Unites (RSUs) granted under the Company's equity plans: 1,340 RSUs which vest in one installment on 1/30/2019; 3,000 RSUs which vest in installments of 1,477 on 5/3/2019 and 1,523 on 5/3/2020; 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021; and 4,508 RSUs which vest in installments of 1,487 on 4/27/2020, 1,488 on 4/27/2021 and 1,533 on 4/27/2022.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 488 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":52202,"source":{"system":"sec-edgar","filing":"0001127602-18-024508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218024508/form4.xml","form_type":"4"}},{"id":129153,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2018-05-07T23:06:57.000Z","date":"2018-05-03","kind":"tax_withholding","acquired":false,"shares":773,"price":169.43,"value":130969.39,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Unites (RSUs) granted under the Company's equity plans: 13,541 RSUs which vest in one installment on 8/1/2018; 1,340 RSUs which vest in one installment on 1/30/2019; 3,000 RSUs which vest in installments of 1,477 on 5/3/2019 and 1,523 on 5/3/2020; and 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,633 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":59382,"source":{"system":"sec-edgar","filing":"0001127602-18-016537","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218016537/form4.xml","form_type":"4"}},{"id":129437,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Nqso (Right to Buy)","published_at":"2018-05-01T23:15:50.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":34702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively."}],"balance_after":34702,"derivative":{"exercise_price":177.46,"exercise_date":"2020-04-27","expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":34702},"source":{"system":"sec-edgar","filing":"0001127602-18-015841","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015841/form4.xml","form_type":"4"}},{"id":129436,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2018-05-01T23:15:50.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":4508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These Restricted Stock Units (RSUs) were granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 13,541 RSUs which vest in one installment on 8/1/2018; 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 1,712 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":60155,"source":{"system":"sec-edgar","filing":"0001127602-18-015841","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015841/form4.xml","form_type":"4"}},{"id":130436,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2018-03-27T23:44:23.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":7549,"price":176.08,"value":1329227.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 13,541 RSUs which vest in one installment on 8/1/2018; 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,712 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":55647,"source":{"system":"sec-edgar","filing":"0001127602-18-012859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218012859/form4.xml","form_type":"4"}},{"id":131006,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2018-03-10T00:30:37.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":15118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 13,541 RSUs which vest in one installment on 8/1/2018; 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,535 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":62913,"source":{"system":"sec-edgar","filing":"0001127602-18-011022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218011022/form4.xml","form_type":"4"}},{"id":133247,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2018-01-31T01:34:54.000Z","date":"2018-01-30","kind":"tax_withholding","acquired":false,"shares":496,"price":198,"value":98208.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 13,541 RSUs which vest in one installment on 8/1/2018; 1,340 RSUs which vest in one installment on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,535 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":47795,"source":{"system":"sec-edgar","filing":"0001127602-18-003051","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218003051/form4.xml","form_type":"4"}},{"id":138568,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2017-08-02T00:50:16.000Z","date":"2017-08-01","kind":"tax_withholding","acquired":false,"shares":7562,"price":174.51,"value":1319644.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 13,541 RSUs which vest in one installment on 8/1/2018; 2,640 RSUs which vest in one installment of 1,300 on 1/30/2018 and one installment of 1/340 on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,261 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":47920,"source":{"system":"sec-edgar","filing":"0001127602-17-024641","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217024641/form4.xml","form_type":"4"}},{"id":140981,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Nqso (Right to Buy)","published_at":"2017-05-04T00:55:17.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":38126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively."}],"balance_after":38126,"derivative":{"exercise_price":162.6,"exercise_date":"2019-05-01","expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":38126},"source":{"system":"sec-edgar","filing":"0001127602-17-016755","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217016755/form4.xml","form_type":"4"}},{"id":140980,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2017-05-04T00:55:17.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":4305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These Restricted Stock Units (RSUs) were granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 27,081 RSUs which vest in one installment of 13,540 on 8/1/2017 and one installment of 13,541 on 8/1/2018; 2,640 RSUs which vest in one installment of 1,300 on 1/30/2018 and one installment of 1/340 on 1/30/2019; 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020; and 4,305 RSUs which vest in installments of 1,420 on 5/1/2019, 1,421 on 5/1/2020 and 1,464 on 5/1/2021.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 1,995 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":55227,"source":{"system":"sec-edgar","filing":"0001127602-17-016755","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217016755/form4.xml","form_type":"4"}},{"id":144389,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2017-02-01T00:21:39.000Z","date":"2017-01-30","kind":"tax_withholding","acquired":false,"shares":529,"price":157.16,"value":83137.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 27,081 RSUs which vest in one installment of 13,540 on 8/1/2017 and one installment of 13,541 on 8/1/2018; 2,640 RSUs which vest in one installment of 1,300 on 1/30/2018 and one installment of 1/340 on 1/30/2019; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,723 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":50690,"source":{"system":"sec-edgar","filing":"0001127602-17-003208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217003208/form4.xml","form_type":"4"}},{"id":150433,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2016-08-04T00:22:40.000Z","date":"2016-08-01","kind":"tax_withholding","acquired":false,"shares":6766,"price":172.03,"value":1163954.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 27,081 RSUs which vest in one installment of 13,540 on 8/1/2017 and one installment of 13,541 on 8/1/2018; 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1/340 on 1/30/2019; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 1,306 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":50741,"source":{"system":"sec-edgar","filing":"0001127602-16-059444","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216059444/form4.xml","form_type":"4"}},{"id":153051,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Nqso (Right to Buy)","published_at":"2016-05-06T00:34:17.000Z","date":"2016-05-03","kind":"grant","acquired":true,"shares":38112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively."}],"balance_after":38112,"derivative":{"exercise_price":156.35,"exercise_date":"2018-05-03","expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":38112},"source":{"system":"sec-edgar","filing":"0001127602-16-051293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216051293/form4.xml","form_type":"4"}},{"id":153050,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2016-05-06T00:34:17.000Z","date":"2016-05-03","kind":"grant","acquired":true,"shares":4477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These Restricted Stock Units (RSUs) were granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 40,621 RSUs which vest in two equal installments of 13,540 on 8/1/2016 and 8/1/2017 and one installment of 13,541 on 8/1/2018; 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1/340 on 1/30/2019; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 1,557 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":57186,"source":{"system":"sec-edgar","filing":"0001127602-16-051293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216051293/form4.xml","form_type":"4"}},{"id":162223,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2015-08-04T22:41:12.000Z","date":"2015-08-01","kind":"tax_withholding","acquired":false,"shares":7196,"price":176.59,"value":1270741.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 40,621 RSUs which vest in two equal installments of 13,540 on 8/1/2016 and 8/1/2017 and one installment of 13,541 on 8/1/2018; and 3,940 RSUs which vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1/340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 782 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":51934,"source":{"system":"sec-edgar","filing":"0001127602-15-024175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215024175/form4.xml","form_type":"4"}},{"id":167232,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2015-02-04T00:07:27.000Z","date":"2015-01-30","kind":"grant","acquired":true,"shares":3940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These Restricted Stock Units (RSUs) were granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 54,161 RSUs which vest in three equal installments of 13,540 on 8/1/2015, 8/1/2016 and 8/1/2017 and one installment of 13,541 on 8/1/2018; and 3,940 RSUs whicdh vest in two equal installments of 1,300 on 1/30/2017 and 1/30/2018 and one installment of 1/340 on 1/30/2019.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 436 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":58537,"source":{"system":"sec-edgar","filing":"0001127602-15-004139","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215004139/form4.xml","form_type":"4"}},{"id":171283,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11935,"kind":"person","name":"Meline David W","position":1,"cik":"0001444612","reported_name":"Meline David W","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Common Stock","published_at":"2014-08-05T20:26:21.000Z","date":"2014-08-01","kind":"grant","acquired":true,"shares":54161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These Restricted Stock Units (RSUs) were granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three equal installments of 13,540 on 8/1/2015, 8/1/2016 and 8/1/2017 and one installment of 13,541 on 8/1/2018.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."}],"balance_after":54161,"source":{"system":"sec-edgar","filing":"0001127602-14-024795","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214024795/form4.xml","form_type":"4"}}]}